Algorhythm Holdings, Inc. filed a current report on September 22, 2026, disclosing the September 21, 2026 termination of a settlement agreement with Continuation Capital, Inc. and a Regulation FD update regarding a revised corporate investor presentation.
Key Highlights
- Settlement terminated: Algorhythm Holdings and Continuation Capital, Inc. agreed to terminate their settlement agreement dated July 21, 2026.
- Original claim amount: The outstanding liabilities covered by the settlement totaled an original principal amount of $1,928,014.
- Remaining balance: The company estimates approximately $1,418,649 remains due under the liabilities originally covered by the agreement.
- Share issuance obligation ended: The termination cancels any further obligation by the company to issue shares to Continuation Capital, Inc. under the settlement.
- Corporate presentation updated: The company updated its investor presentation on September 22, 2026, intending to use it in investor meetings and on its website.
Algorhythm Holdings Ends Share-Based Debt Settlement and Updates Investor Materials
According to the filing, Algorhythm Holdings, Inc. (NASDAQ:RIME), a Delaware-incorporated company headquartered in Fort Lauderdale, Florida, entered into the original settlement agreement with Continuation Capital, Inc. on July 21, 2026. Under that agreement, CCI had acquired certain outstanding liabilities of Algorhythm Holdings from their former holders, with the covered liabilities carrying an original principal amount of $1,928,014. To satisfy those obligations, the company had agreed to issue CCI up to 5,000,000 shares of common stock, par value $0.01 per share, in one or more tranches, continuing until CCI generated aggregate proceeds equal to 120% of the claim amount.
The September 21, 2026 termination, as disclosed in the filing, ends any further obligation on the part of the company to issue additional shares under the settlement. The company disclosed that it estimates a remaining balance of approximately $1,418,649 is still due under the liabilities that had been covered by the now-terminated agreement. The filing does not specify how this remaining balance will be addressed going forward.
Separately, under Item 7.01, the company disclosed that it updated its corporate presentation on September 22, 2026, furnishing it as Exhibit 99.1. The filing notes that the presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, and that those statements are subject to risks and uncertainties described in the company's periodic reports filed with the SEC, including its Annual Report for the year ended December 31, 2025. The company cautioned that readers should not place undue reliance on any forward-looking statement contained in the presentation.
What Was Disclosed
Algorhythm Holdings reported the mutual termination of a July 21, 2026 settlement agreement with Continuation Capital, Inc., ending the company's obligation to issue up to 5,000,000 shares, while estimating approximately $1,418,649 in liabilities remains outstanding. The company also updated its corporate investor presentation.



Please wait processing your request...